Kupea: Improving cervical cancer prevention for people with HIV in Malawi
Official title: Kupewa: Optimizing implementation strategies for cervical cancer prevention
Funded at New York University · NIH-11535284 · Data updated 2026-11-12
A Johns Hopkins-like project in Malawi tests ways to make cervical cancer prevention easier to reach for people living with HIV.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | New York University NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | September 1, 2024 |
| Project end | August 31, 2029 |
| Funding year | 2026 |
| Award (this year) | $216,021 |
| NIH project number | 3U01CA294756-03S1 |
| Project ID | NIH-11535284 on NIH RePORTER |
Who could benefit from this research
✓Could help
People living with HIV in Malawi who are eligible for cervical cancer prevention.
✕Less likely to help
If a participant does not engage with the prevention services, they may not experience direct benefit.
What this research studies
This project studies how to put guideline-based cervical cancer prevention into practice in a low-resource setting. Researchers will test different implementation strategies to see which reach more people, what makes them easier to use, and which are sustainable over time. The study plans to refine these strategies by adding information about how feasible they are in real-world settings and by measuring their impact on prevention delivery. The ultimate goal is to identify a set of effective, practical, and lasting approaches that could improve prevention for people living with HIV in Malawi and potentially inform care in the United States. The work blends implementation science with intervention optimization to generate actionable evidence for public health programs.
Why it matters
Potential benefit: Could lead to more people with HIV receiving effective cervical cancer prevention services.
How similar studies have gone: Early work in implementation science suggests that context-adapted, optimized strategies can improve prevention uptake in similar settings.
Where this research is happening
-
New York University
New York, United States Active
Researchers
- Principal investigator: Moucheraud, Corrina — New York University
- Study coordinator: Moucheraud, Corrina
Related research
Other NIH-funded projects on the same topics.
-
Community and digital tools to reduce HPV and cervical cancer burden
A nurse or health team will test a community-based, digital strategy to help girls and young women, especially in rural areas, get HPV vaccination and cervical cancer prevention services.
-
Community and digital tools to reduce HPV and cervical cancer in women with HIV
A community- and digital-technology program aims to help girls and young women, including those with HIV, get more HPV vaccination and cervical cancer prevention services.
-
mSaada: a mobile tool to boost cervical cancer screening in western Kenya
A mobile app helps community health volunteers manage cervical cancer screening tasks and follow-up for women in low-resource areas.
-
Globally useful predictor for cervical cancer treatment response
This project aims to develop a simple predictive signature to personalize treatment for locally advanced cervical cancer using easy tests and imaging.
-
HPV self-collection in HIV care to screen for cervical cancer in Ethiopia
A patient-centered program tests a simple HPV self-collection approach within HIV clinics in Ethiopia to help detect cervical cancer earlier.
-
Hybrid approach to boost cervical cancer screening in Uganda
A tested, community-driven program helps Ugandan women encourage their peers to get free VIA cervical cancer screening.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.